Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Kt as control and follow-up of the dose at a hemodialysis unit].
Maduell F, Vera M, Serra N, Collado S, Carrera M, Fernández A, Arias M, Blasco M, Burgadá E, Cases A, Campistol JM. Maduell F, et al. Among authors: cases a. Nefrologia. 2008;28(1):43-7. Nefrologia. 2008. PMID: 18336130 Free article. Spanish.
Treatment of hyperkalaemia in renal failure: salbutamol v. insulin.
Lens XM, Montoliu J, Cases A, Campistol JM, Revert L. Lens XM, et al. Among authors: cases a. Nephrol Dial Transplant. 1989;4(3):228-32. doi: 10.1093/oxfordjournals.ndt.a091860. Nephrol Dial Transplant. 1989. PMID: 2498781 Clinical Trial.
Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine.
Cases A, Kelly J, Sabater J, Campistol JM, Torras A, Montoliu J, López I, Revert L. Cases A, et al. Clin Nephrol. 1988 Apr;29(4):176-8. Clin Nephrol. 1988. PMID: 3365862
We report 5 cases of acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. Four patients complained of visual toxicity characterized by a decrease in visual acuity, loss of color vision and night blindness. In th …
We report 5 cases of acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. Four …
Improvement of renal function in azotaemic hypertensive patients after surgical revascularization.
Mestres CA, Campistol JM, Ninot S, Botey A, Abad C, Guerola M, Cases A, Revert L, Mulet J. Mestres CA, et al. Among authors: cases a. Br J Surg. 1988 Jun;75(6):578-80. doi: 10.1002/bjs.1800750626. Br J Surg. 1988. PMID: 3395825
Mean serum creatinine showed a decrease from 3.76 to 1.65 mg/dl (P less than 0.005). Mean arterial pressure dropped from 161 mmHg to 103 mmHg (P less than 0.001). ...We conclude that renal revascularization surgery is a reliable and efficient form of treatment in se …
Mean serum creatinine showed a decrease from 3.76 to 1.65 mg/dl (P less than 0.005). Mean arterial pressure dropped from 161 mmHg to …
Visceral involvement of dialysis amyloidosis.
Campistol JM, Cases A, Torras A, Soler M, Muñoz-Gómez J, Montoliu J, López-Pedret J, Revert L. Campistol JM, et al. Among authors: cases a. Am J Nephrol. 1987;7(5):390-3. doi: 10.1159/000167505. Am J Nephrol. 1987. PMID: 3434597
Correction of uremic platelet dysfunction after renal transplantation.
Campistol JM, Cofan F, Díaz Ricart M, Tassies D, Cases A, Torregrosa JV, Ricart J, Vilardell J, Oppenheimer F, Escolar G. Campistol JM, et al. Among authors: cases a. Transplant Proc. 1995 Aug;27(4):2244-5. Transplant Proc. 1995. PMID: 7652791 Clinical Trial. No abstract available.
229 results